Erratum: FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxyl-5,4'-di-n-octyl genistein (Molecular Medicine Reports (2014) 9 (1982-1988) DOI: 10.3892/mmr.2014.2012);FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxyl-5, 4'-di-n-octyl genistein

Molecular Medicine Reports

Volumn 9, Issue 5, 2014, Pages 1982-1988

  Ning, Yingxia ^a   Luo, Chaoyuan ^a   Ren, Kaiqun ^b   Quan, Meifang ^b   Cao, Jianguo ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b HUNAN NORMAL UNIVERSITY   (China)

Author keywords

7 Difluoromethoxyl 5,4' di n octyl genistein; Cancer stem cells; FOXO3a; Ovarian cancer; Self renewal

Indexed keywords

7 DIFLUOROMETHOXYL 5,4' DI N OCTYL GENISTEIN; BETA ACTIN; BMI1 PROTEIN; CD133 ANTIGEN; GENISTEIN; HERMES ANTIGEN; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CARCINOGENICITY; CELL PROLIFERATION; CELL RENEWAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MOUSE; NONHUMAN; OVARIAN CANCER CELL LINE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SPHERE FORMING CELL; TUMOR SPHEROID; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE KNOCKOUT TECHNIQUES; GENISTEIN; HETEROGRAFTS; HUMANS; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PHOSPHORYLATION; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELL ASSAY;

EID: 84899533453     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2021.12449     Document Type: Erratum

References (32)

1. Jemal A, Center MM, Ward E and Thun MJ: Cancer occurrence. Methods Mol Biol 471: 3-29, 2009.
2. Schwartz PE: Current diagnosis and treatment modalities for ovarian cancer. Cancer Treat Res 107: 99-118, 2002.
3. Almanaa TN, Geusz ME and Jamasbi RJ: Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines. BMC Complement Altern Med 12: 195, 2012.
4. Quitschke WW: Curcuminoid binding to embryonal carcinoma cells: reductive metabolism, induction of apoptosis, senescence, and inhibition of cell proliferation. PLoS One 7: e39568, 2012.
5. Chen SF, Nieh S, Jao SW, et al: Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells. PLoS One 7: e49275, 2012.
6. Lee CH, Hong HM, Chang YY and Chang WW: Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells. Biochimie 94: 1382-1389, 2012.
7. Montales MT, Rahal OM, Kang J, et al: Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells. Carcinogenesis 33: 652-660, 2012.
8. Bao B, Wang Z, Ali S, et al: Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem 112: 2296-2306, 2011.
9. Bao B, Wang Z, Ali S, et al: Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett 307: 26-36, 2011.
10. Rodova M, Fu J, Watkins DN, Srivastava RK and Shankar S: Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal. PLoS One 7: e46083, 2012.
11. Kallifatidis G, Labsch S, Rausch V, et al: Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther 19: 188-195, 2011.
12. Rausch V, Liu L, Kallifatidis G, et al: Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics. Cancer Res 70: 5004-5013, 2010.
13. Li Y, Zhang T, Korkaya H, et al: Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res 16: 2580-2590, 2010.
14. Chaudhuri D, Orsulic S and Ashok BT: Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells. Mol Cancer Ther 6: 334-345, 2007.
15. Chen D, Pamu S, Cui Q, Chan TH and Dou QP: Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells. Bioorg Med Chem 20: 3031-3037, 2012.
16. Nishimura N, Hartomo TB, Pham TV, et al: Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells. Environ Health Prev Med 17: 246-251, 2012.
17. Xiang HL, Liu F, Quan MF, Cao JG and Lv Y: 7-difluoromethoxyl-5,4'-di-n- octylgenistein inhibits growth of gastric cancer cells through downregulating forkhead box M1. World J Gastroenterol 18: 4618-4626, 2012.
18. Ning Y, Li Q, Xiang H, Liu F and Cao J: Apoptosis induced by 7-difluoromethoxyl-5,4'-di-n-octyl genistein via the inactivation of FoxM1 in ovarian cancer cells. Oncol Rep 27: 1857-1864, 2012.
19. Sunayama J, Sato A, Matsuda K, et al: FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity. Stem Cells 29: 1327-1337, 2011.
20. Shiota M, Song Y, Yokomizo A, et al: Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation. Clin Cancer Res 16: 5654-5663, 2010.
21. Wu KJ and Yang MH: Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection. Biosci Rep 31: 449-455, 2011.
22. Dubrovska A, Kim S, Salamone RJ, et al: The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 106: 268-273, 2009.
23. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
24. Kakarala M and Wicha MS: Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 26: 2813-2820, 2008.
25. Sakariassen PØ, Immervoll H and Chekenya M: Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia 9: 882-892, 2007.
26. Tang C, Chua CL and Ang BT: Insights into the cancer stem cell model of glioma tumorigenesis. Ann Acad Med Singapore 36: 352-357, 2007.
27. Lippman ME: High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer. N Engl J Med 342: 1119-1120, 2000.
28. Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA and Loehrer PJ: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316: 1435-1440, 1987.
29. Liu T, Cheng W, Lai D, Huang Y and Guo L: Characterization of primary ovarian cancer cells in different culture systems. Oncol Rep 23: 1277-1284, 2010.
30. Ma L, Lai D, Liu T, Cheng W and Guo L: Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Acta Biochim Biophys Sin (Shanghai) 42: 593-602, 2010.
31. Li Y, Chen H, Hardy TM and Tollefsbol TO: Epigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genistein. PLoS One 8: e54369, 2013.
32. Regenbrecht CR, Jung M, Lehrach H and Adjaye J: The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines. BMC Med Genomics 1: 49, 2008.